Möchten Sie immer auf dem neuesten Stand bleiben?

New preclinical data demonstrate that SIL204 treatment produced statistically significant upregulation of FAS (CD95), the immune “death receptor,” and statistically significant downregulation of...

Combined sample-to-report solution pairs PacBio HiFi WGS with GenomOncology Pathology Workbench to support clinical genomic labs.

Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears...

Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The "Southeast Asia Oncology Drug Access Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. ...

Dublin, July 07, 2026 (GLOBE NEWSWIRE) -- The "Exosome Diagnostics Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The Exosome...

Austin, United States, July 01, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Multi-Cancer Early Detection Market was valued at USD 1.47 Billion in 2025 and is projected to reach USD 7.04...

Austin, United States, June 25, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the Breast Cancer Liquid Biopsy Market Size was valued at USD 1.33 Billion in 2025 and is projected to reach USD...

CTA Approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from the Ethics Committee of the North Rhine Medical Association, clears Silexion...

Austin, United States, June 22, 2026 (GLOBE NEWSWIRE) -- The Laboratory Developed Tests Market was valued at USD 14.27 Billion in 2025 and is expected to reach USD 28.31 Billion by 2035, growing at...

Boehringer Ingelheim is committed to improving outcomes for people facing aggressive cancers where there are currently few treatment optionsDAREON®-Lung-1 and DAREON®-NEC-1 will evaluate obrixtamig as...